Free Trial

Best Biotechnology Stocks

Compare the best biotech stocks to buy today. 

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PricePE RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$203.55
-0.2%
70.68$359.54 billion4.34 million5.33 millionEarnings Report
Dividend Increase
Analyst Forecast
Short Interest ↑
Analyst Revision
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$557.92
+2.1%
34.98$213.13 billion1.41 million1.47 millionInsider Selling
Danaher Co. stock logo
DHR
Danaher
$247.82
+0.9%
47.29$178.99 billion2.64 million2.75 millionAnalyst Upgrade
Short Interest ↓
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$471.12
-1.0%
N/A$121.60 billion1.34 million1.17 millionUpcoming Earnings
Analyst Forecast
GSK plc stock logo
GSK
GSK
$36.87
+0.3%
23.94$76.41 billion6.88 million3.86 millionDividend Increase
Analyst Downgrade
Gap Up
Cencora, Inc. stock logo
COR
Cencora
$234.27
+2.7%
25.44$46.16 billion1.61 million1.41 millionUpcoming Earnings
Short Interest ↓
Positive News
Takeda Pharmaceutical Company Limited stock logo
TAK
Takeda Pharmaceutical
$13.96
+0.1%
26.34$44.42 billion811,6791.85 millionNews Coverage
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$209.16
+1.6%
27.16$38.13 billion1.46 million1.09 millionAnalyst Upgrade
Short Interest ↓
News Coverage
Cognizant Technology Solutions Co. stock logo
CTSH
Cognizant Technology Solutions
$74.61
+0.0%
16.51$36.98 billion4.10 million3.83 millionEarnings Report
Dividend Announcement
Analyst Downgrade
Analyst Revision
News Coverage
argenx SE stock logo
ARGX
argenx
$595.58
+1.6%
N/A$35.61 billion449,545309,272Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$273.91
+2.7%
N/A$35.16 billion866,294871,240Analyst Forecast
Short Interest ↑
News Coverage
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$212.80
+1.9%
56.75$34.46 billion576,424938,127Analyst Downgrade
BioNTech SE stock logo
BNTX
BioNTech
$111.48
-1.4%
N/A$26.51 billion984,800783,669Upcoming Earnings
Illumina, Inc. stock logo
ILMN
Illumina
$149.76
+3.9%
N/A$22.96 billion1.71 million1.99 millionUpcoming Earnings
Moderna, Inc. stock logo
MRNA
Moderna
$54.63
+0.5%
N/A$20.90 billion4.77 million4.35 millionUpcoming Earnings
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$227.10
-0.5%
43.93$18.99 billion636,932668,388Analyst Upgrade
ICON Public Limited stock logo
ICLR
ICON Public
$220.40
-0.8%
24.57$18.18 billion1.49 million654,069High Trading Volume
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$374.02
+0.0%
16.43$16.64 billion426,943466,657Earnings Report
Analyst Forecast
Insider Selling
News Coverage
Positive News
Royalty Pharma plc stock logo
RPRX
Royalty Pharma
$27.10
+0.4%
23.98$16.02 billion1.81 million2.57 millionUpcoming Earnings
Revvity, Inc. stock logo
RVTY
Revvity
$121.04
+2.1%
87.71$14.93 billion1.45 million818,094Upcoming Earnings
Suzano S.A. stock logo
SUZ
Suzano
$10.22
-0.5%
16.21$13.53 billion2.39 million1.83 million
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$107.29
+0.9%
N/A$11.97 billion543,349831,148Upcoming Earnings
Positive News
Catalent, Inc. stock logo
CTLT
Catalent
$58.73
+0.2%
N/A$10.66 billion1.70 million2.04 million
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$319.56
+1.7%
27.98$9.93 billion307,867275,053
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$180.96
+1.3%
21.67$9.34 billion830,099605,613Upcoming Earnings
Short Interest ↑
Analyst Revision
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$334.85
N/A$9.33 billion8121News Coverage
High Trading Volume
Fabrinet stock logo
FN
Fabrinet
$242.53
+0.6%
29.94$8.80 billion867,298480,160Upcoming Earnings
Short Interest ↑
News Coverage
Positive News
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$44.36
-1.5%
N/A$8.09 billion1.51 million1.06 millionAnalyst Forecast
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$142.78
+1.8%
N/A$7.22 billion1.39 million1.45 millionPositive News
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$176.39
+2.2%
48.33$5.07 billion296,889327,397Upcoming Earnings
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$65.35
+2.3%
N/A$4.48 billion1.45 million1.41 millionUpcoming Earnings
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$26.90
+7.3%
44.10$4.16 billion5.71 million3.62 millionUpcoming Earnings
Analyst Forecast
News Coverage
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$27.05
+4.2%
N/A$3.87 billion837,7091.08 millionUpcoming Earnings
Analyst Forecast
News Coverage
Gap Up
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$5.28
+1.3%
N/A$3.68 billion4.43 million4.94 million
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$11.47
+0.4%
N/A$3.40 billion2.30 million2.71 millionUpcoming Earnings
Analyst Downgrade
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$11.19
+7.2%
N/A$3.13 billion5.30 million7.12 millionUpcoming Earnings
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$19.26
-2.6%
9.53$3.13 billion2.07 million917,028Earnings Report
Dividend Announcement
Analyst Forecast
Short Interest ↑
News Coverage
High Trading Volume
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$28.74
-0.4%
N/A$2.89 billion961,8851.50 millionUpcoming Earnings
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$43.82
+8.5%
N/A$2.40 billion1.40 million911,312Insider Selling
Twist Bioscience Co. stock logo
TWST
Twist Bioscience
$41.57
+3.0%
N/A$2.36 billion657,366945,058
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Apogee Therapeutics, Inc. stock logo
APGE
Apogee Therapeutics
$54.49
+4.7%
N/A$2.34 billion466,684495,568
SpringWorks Therapeutics, Inc. stock logo
SWTX
SpringWorks Therapeutics
$30.62
+1.6%
N/A$2.24 billion481,115953,954
Bloom Energy Co. stock logo
BE
Bloom Energy
$9.96
+3.8%
N/A$2.19 billion5.95 million5.81 millionUpcoming Earnings
Analyst Forecast
Oddity Tech Ltd. stock logo
ODD
Oddity Tech
$38.07
-0.8%
27.00$2.17 billion268,101673,224Upcoming Earnings
Standex International Co. stock logo
SXI
Standex International
$180.38
-1.9%
29.57$2.15 billion50,77356,731Earnings Report
Analyst Forecast
Analyst Revision
Azenta, Inc. stock logo
AZTA
Azenta
$41.22
+0.3%
N/A$2.02 billion497,990492,533
10x Genomics, Inc. stock logo
TXG
10x Genomics
$16.33
+1.9%
N/A$1.97 billion1.90 million1.71 millionEarnings Report
Analyst Forecast
Analyst Revision
News Coverage
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$22.93
+4.7%
N/A$1.89 billion777,4931.22 millionUpcoming Earnings
Arvinas, Inc. stock logo
ARVN
Arvinas
$26.90
+1.8%
N/A$1.85 billion602,734719,515Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$6.40
+1.3%
N/A$1.80 billion3.63 million5.67 millionUpcoming Earnings
Galapagos NV stock logo
GLPG
Galapagos
$26.89
+1.7%
N/A$1.77 billion466,666135,762Analyst Forecast
News Coverage
High Trading Volume
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$8.43
+5.2%
N/A$1.74 billion2.88 million2.94 millionUpcoming Earnings
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$33.98
+4.5%
N/A$1.73 billion387,761508,509Positive News
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$13.83
+0.9%
N/A$1.73 billion642,0131.10 millionAnalyst Forecast
Immunocore Holdings plc stock logo
IMCR
Immunocore
$31.70
+2.8%
N/A$1.59 billion298,637532,678Upcoming Earnings
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$16.98
+2.0%
N/A$1.55 billion497,445776,938Upcoming Earnings
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$16.85
+0.2%
N/A$1.51 billion1.21 million1.27 millionUpcoming Earnings
Novavax, Inc. stock logo
NVAX
Novavax
$9.35
-2.7%
N/A$1.50 billion4.42 million9.92 million
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$22.28
+3.3%
N/A$1.42 billion1.23 million1.11 million
Tutor Perini Co. stock logo
TPC
Tutor Perini
$26.29
+1.4%
N/A$1.38 billion404,804445,794Upcoming Earnings
Evotec SE stock logo
EVO
Evotec
$3.88
+0.3%
N/A$1.37 billion345,450107,198Upcoming Earnings
High Trading Volume
Oaktree Specialty Lending Co. stock logo
OCSL
Oaktree Specialty Lending
$15.96
-1.6%
18.34$1.31 billion601,466659,369Analyst Forecast
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$11.72
+2.0%
N/A$1.28 billion812,3341.41 millionUpcoming Earnings
UPB
Upstream Bio
$24.76
-0.2%
N/A$1.27 billion346,591347,119
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.26
+23.6%
N/A$1.27 billion7.29 million1.02 millionEarnings Report
Analyst Forecast
Options Volume
News Coverage
Gap Down
High Trading Volume
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
$26.21
+1.6%
N/A$1.24 billion1.38 million1.71 millionUpcoming Earnings
News Coverage
Phreesia, Inc. stock logo
PHR
Phreesia
$18.47
+1.0%
N/A$1.07 billion241,085447,610
Zymeworks Inc. stock logo
ZYME
Zymeworks
$13.28
-3.1%
N/A$973.34 million1.21 million625,201Earnings Report
Analyst Downgrade
News Coverage
Gap Down
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$16.22
-5.4%
N/A$962.17 million107,428309,444Short Interest ↓
Gap Up
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
$20.37
+4.5%
N/A$934.98 million95,811260,002Short Interest ↑
Abrdn Healthcare Investors stock logo
HQH
Abrdn Healthcare Investors
$18.16
+0.7%
N/A$919.35 million228,211156,674News Coverage
Positive News
Rapport Therapeutics stock logo
RAPP
Rapport Therapeutics
$24.62
+0.4%
N/A$900.60 million30,886165,505Gap Up
Prothena Co. plc stock logo
PRTA
Prothena
$16.65
-2.1%
N/A$895.44 million512,028589,349Upcoming Earnings
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$26.41
+0.8%
18.47$892.66 million187,735190,328Upcoming Earnings
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$19.45
-3.2%
N/A$883.22 million803,3671.15 million
Transcat, Inc. stock logo
TRNS
Transcat
$95.41
-0.2%
48.19$873.00 million120,82453,096Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
High Trading Volume
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$16.39
-1.7%
N/A$865.56 million523,107186,846Upcoming Earnings
Insider Buying
High Trading Volume
SLR Investment Corp. stock logo
SLRC
SLR Investment
$15.28
-0.6%
8.22$833.68 million138,933157,839Upcoming Earnings
Analyst Forecast
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$28.01
+0.5%
N/A$818.14 million154,009194,024Positive News
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$3.66
+4.6%
N/A$814.24 million1.32 million2.15 million
Replimune Group, Inc. stock logo
REPL
Replimune Group
$11.90
+1.2%
N/A$803.46 million644,9911.06 millionUpcoming Earnings
Adaptive Biotechnologies Co. stock logo
ADPT
Adaptive Biotechnologies
$5.31
+9.7%
N/A$783.08 million959,0031.41 millionUpcoming Earnings
Wabash National Co. stock logo
WNC
Wabash National
$17.45
+0.1%
N/A$756.28 million571,141596,003Analyst Revision
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.99
+1.5%
N/A$738.59 million2.51 million2.47 millionEarnings Report
Analyst Forecast
News Coverage
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$69.68
+1.0%
47.95$701.68 million46,46670,724
Immunome, Inc. stock logo
IMNM
Immunome
$11.59
+1.0%
N/A$695.98 million632,566761,861Short Interest ↓
Gap Up
BlackRock TCP Capital Corp. stock logo
TCPC
BlackRock TCP Capital
$8.00
-0.2%
N/A$684.72 million410,098489,671Upcoming Earnings
Analyst Forecast
TRML
Tourmaline Bio
$26.30
+3.1%
N/A$674.33 million93,844305,031
Avid Bioservices, Inc. stock logo
CDMO
Avid Bioservices
$10.27
+3.1%
N/A$655.12 million494,0921.07 millionPositive News
Entrada Therapeutics, Inc. stock logo
TRDA
Entrada Therapeutics
$17.60
+2.7%
5.95$654.72 million83,564103,514Upcoming Earnings
Positive News
The most serious warning of my career (Ad)

With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Click here now to grab your seat now.
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$10.27
-0.5%
N/A$649.99 million259,21893,466Positive News
High Trading Volume
Revance Therapeutics, Inc. stock logo
RVNC
Revance Therapeutics
$5.80
-1.7%
N/A$607.96 million1.67 million2.73 millionAnalyst Forecast
Neurogene Inc. stock logo
NGNE
Neurogene
$46.07
+4.7%
N/A$598.45 million91,502119,127
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$21.68
+0.2%
N/A$594.77 million502,493343,608Upcoming Earnings
Analyst Forecast
News Coverage
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
$47.43
+0.4%
N/A$572.01 million42,98267,003News Coverage
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$27.78
+2.1%
56.70$555.88 million202,707132,919
Celcuity Inc. stock logo
CELC
Celcuity
$14.93
-3.7%
N/A$552.86 million158,848275,416Short Interest ↑
News Coverage
Positive News
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$5.15
-5.2%
N/A$551.77 million2.71 million781,316High Trading Volume
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$8.90
+4.7%
N/A$546.19 million745,700727,342Insider Selling
Analyst Revision
Silence Therapeutics plc stock logo
SLN
Silence Therapeutics
$17.68
+2.2%
N/A$529.16 million132,646200,390

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.


(Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.



More Stock Ideas from MarketBeat